Hot Products
| Catalog No. | Information |
| CFN97096 | Erythrinin C Standard reference |
| CFN98351 | Erythristemine (+)-Erythristemine shows moderate toxicity to brine shrimp (LC50 23 ppm) and moderate (IC50=86microg/ml) radical scavenging properties against stable 2,2-diphenyl-1-picrylhy--drazyl (DPPH) radical. |
| CFN99620 | Erythritol Erythritol is a biological sweetener with applications in food and pharmaceutical industries, it is also used as a functional sugar substitute in special foods for people with diabetes and obesity because of its unique nutritional properties. Erythritol consumption acutely improved small vessel endothelial function, and chronic treatment reduced central aortic stiffness, may be as a preferred sugar substitute for patients with diabetes mellitus. |
| CFN98914 | Erythrodiol Erythrodiol is the precursor of pentacyclic triterpenic acids, it exerts antiproliferative and proapoptotic activity in colon adenocarcinoma cells. Erythrodiol may have interesting therapeutic potential as new vasodilator drugs, thus protecting the cardiovascular system. |
| CFN95416 | Erythro-Guaiacylglycerol-beta-coniferyl aldehyde ether Erythro-Guaiacylglycerol-beta-coniferyl aldehyde ether,cytotoxic effects on human cancer cell lines |
| CFN95363 | Eschweilenol C Eschweilenol C has antifungal, anti-inflammatory, antioxidant, antidiabetic activity. 4-(alpha-rhamnopyranosyl)ellagic acid is an inhibitor of human recombinant aldose reductase HRAR (IC50 = 4.1 x 10(-8) M). |
| CFN93368 | Escin IA Escin IA is a prodrug and its structure can be converted to desacylescin I by human intestinal bacteria and Lactobacillus brevis., desacylescin I as a biotransformation product shows potentially inhibitory effects on mouse tumor, and a potential candidate for anti tumor agents. Escin IA has anti-TNBC metastasis activity, and its action mechanisms involved inhibition of EMT process by down-regulating LOXL2 expression. |
| CFN90934 | Escin IB Escin Ib inhibits gastric emptying, at least in part, mediated by capsaicin-sensitive sensory nerves, to stimulate the synthesis and/or release of dopamine, to act through central dopamine2 receptor, which in turn causes the release of PGs. |
| CFN99059 | Esculentic acid Esculentic acid has anti-inflammatory effect, it has protective effects against LPS-induced endotoxic shock may be mediated, at least in part, by regulation the release of inflammatory cytokines and mediators, and protein expression of COX-2 in mice. |
| CFN98162 | Esculentoside A Esculentoside A has anti-inflammatory activity , can suppress inflammatory responses in LPS-induced ALI through inhibition of the nuclear factor kappa B and mitogen activated protein kinase signaling pathways. Esculentoside A may be useful for the treatment of autoimmune disease through modulation on T cell-mediated adaptive immunity. Esculentoside A treatment can attenuate CCl4 and GalN/LPS-induced acute liver injury in mice. |
